Coronavirus continues to draw interest and headlines. In the US, it is still seen as the most important problem (
https://news.gallup.com/poll/1675/most-important-problem.aspx). For each of the past few days in India, more than 300,000 people have been confirmed to be newly infected with coronavirus, higher than the US's peak in January.
France has been unable to develop its own vaccine for COVID-19. For details, see "After vaccine failures, France laments biomedical decline":
https://science.sciencemag.org/content/372/6540/331. As a result, France's government plans to raise research and development spending from 2.2% to 3% of GDP, with €5 billion per year of that coming from public spending.